索拉非尼成功诱导一名伴有难治性急性红白血病和细胞遗传学异常的FLT3-ITD阳性患者实现缓解，并长期完全缓解。 - Suppr | 超能文献

The successful remission induction by sorafenib and long-term complete remission in a FLT3-ITD-positive patient with a refractory acute erythroid leukemia and abnormal cytogenetics.

作者信息

Mori Masanori, Sprague Julian

出版信息

Leuk Res. 2012 Jan;36(1):e1-3. doi: 10.1016/j.leukres.2011.09.023. Epub 2011 Oct 11.

DOI:10.1016/j.leukres.2011.09.023

Abstract

摘要

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1

The successful remission induction by sorafenib and long-term complete remission in a FLT3-ITD-positive patient with a refractory acute erythroid leukemia and abnormal cytogenetics.索拉非尼成功诱导一名伴有难治性急性红白血病和细胞遗传学异常的FLT3-ITD阳性患者实现缓解，并长期完全缓解。

Leuk Res. 2012 Jan;36(1):e1-3. doi: 10.1016/j.leukres.2011.09.023. Epub 2011 Oct 11.

2

Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation.索拉非尼用于异基因干细胞移植后难治性FMS样酪氨酸激酶受体-3（FLT3/ITD+）急性髓系白血病

Leuk Res. 2011 Mar;35(3):422-3. doi: 10.1016/j.leukres.2010.10.025. Epub 2010 Nov 18.

3

Complete resolution of leukemia cutis with sorafenib in an acute myeloid leukemia patient with FLT3-ITD mutation.在一名携带FLT3-ITD突变的急性髓系白血病患者中，索拉非尼使皮肤白血病完全消退。

Am J Hematol. 2009 Oct;84(10):701-2. doi: 10.1002/ajh.21511.

4

Secondary resistance to sorafenib in two patients with acute myeloid leukemia (AML) harboring FLT3-ITD mutations.两名携带FLT3-ITD突变的急性髓系白血病（AML）患者对索拉非尼产生继发性耐药。

Ann Hematol. 2011 Apr;90(4):473-5. doi: 10.1007/s00277-010-1027-9. Epub 2010 Jul 21.

5

Marked bone marrow hypoplasia associated with sorafenib-induced marrow blast clearance in two patients with FLT3-ITD acute myeloid leukemia.在两名伴有FLT3-ITD急性髓系白血病的患者中，索拉非尼诱导骨髓原始细胞清除导致显著的骨髓增生低下。

Leuk Res. 2011 Mar;35(3):e21-2. doi: 10.1016/j.leukres.2010.10.028. Epub 2010 Dec 8.

6

Sorafenib (Nexavar) induces molecular remission and regression of extramedullary disease in a patient with FLT3-ITD+ acute myeloid leukemia.索拉非尼（多吉美）可使一名FLT3-ITD+急性髓系白血病患者出现分子缓解并使髓外疾病消退。

Leuk Res. 2009 Feb;33(2):348-50. doi: 10.1016/j.leukres.2008.04.017. Epub 2008 Jun 24.

7

Compassionate use of sorafenib in FLT3-ITD-positive acute myeloid leukemia: sustained regression before and after allogeneic stem cell transplantation.索拉非尼在FLT3-ITD阳性急性髓系白血病中的同情用药：异基因造血干细胞移植前后的持续缓解

Blood. 2009 Jun 25;113(26):6567-71. doi: 10.1182/blood-2009-03-208298. Epub 2009 Apr 23.

8

[Prevalence and clinical significance of FLT3 internal tandem duplication mutation in acute leukemia].[急性白血病中FLT3内部串联重复突变的患病率及临床意义]

Zhonghua Xue Ye Xue Za Zhi. 2004 Jul;25(7):393-6.

9

Flt3 internal tandem duplication and P-glycoprotein functionality in 171 patients with acute myeloid leukemia.171例急性髓系白血病患者的Flt3内部串联重复与P-糖蛋白功能

Clin Cancer Res. 2006 Dec 1;12(23):7018-24. doi: 10.1158/1078-0432.CCR-06-0641.

10

High activity of sorafenib in FLT3-ITD-positive acute myeloid leukemia synergizes with allo-immune effects to induce sustained responses.索拉非尼在 FLT3-ITD 阳性急性髓系白血病中的高活性与同种免疫效应协同作用，诱导持续缓解。

Leukemia. 2012 Nov;26(11):2353-9. doi: 10.1038/leu.2012.105. Epub 2012 Apr 16.

引用本文的文献

1

A Carbon 21 Steroidal Glycoside with Pregnane Skeleton from Bunge Promotes Megakaryocytic and Erythroid Differentiation in Erythroleukemia HEL Cells through Regulating Platelet-Derived Growth Factor Receptor Beta and JAK2/STAT3 Pathway.一种从白刺中分离得到的具有孕甾烷骨架的C21甾体糖苷通过调节血小板衍生生长因子受体β和JAK2/STAT3信号通路促进红白血病HEL细胞向巨核细胞和红细胞分化。

Pharmaceuticals (Basel). 2024 May 14;17(5):628. doi: 10.3390/ph17050628.

2

Prognosis and outcome of patients with acute myeloid leukemia based on mutation with or without additional abnormal cytogenetics.基于伴有或不伴有其他细胞遗传学异常的突变的急性髓系白血病患者的预后和结局

Oncol Lett. 2019 Dec;18(6):6766-6774. doi: 10.3892/ol.2019.11051. Epub 2019 Nov 5.

3

Precision therapy for acute myeloid leukemia.精准治疗急性髓系白血病。

J Hematol Oncol. 2018 Jan 5;11(1):3. doi: 10.1186/s13045-017-0543-7.